None of the GRN pathogenic variant carriers showed a predominant bulbar ALS-MP, and no MAPT pathogenic variant carrier showed a predominant PSP-MP or mixed/ALS-MP. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.